- Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma. Motzer, R.J., Hudes, G.R., Curti, B.D., McDermott, D.F., Escudier, B.J., Negrier, S., Duclos, B., Moore, L., O'Toole, T., Boni, J.P., Dutcher, J.P. J. Clin. Oncol. (2007)